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Abstract 
Using the biotin-streptavidin interaction as a model, we investigated the suitability of lanthanide chelates as encapsulated liposomal 
labels in liposome-based binding assays. Large unilamellar phospholipid:cholesterol liposomes containing europium-DTPA chelate and 
biotinylated phosphatidylethanolamine were prepared by detergent dialysis. The resulting Eu-liposomes (Q 120 nm) bound specifically to 
streptavidin i  microtiter wells as measured by time-resolved fluorometric assay (TRF). The intensity of fluorescence r leased from the 
bound liposomes was dependent on the concentration f biotin in the liposome membrane, the concentration f europium entrapped in the 
liposomes, the incubation time and the amount of liposomes used in the assay. The sensitivity of the TRF assay allowed the detection of 
binding of attomole quantities of liposomes. The streptavidin-immobilised liposomes ubjected to porcine pancreatic phospholipase A 2 
(EC 3.1.1.4) and detergents displayed a dose-dependent release of the encapsulated uropium. Lanthanide-chelate-liposomes should prove 
useful for studies addressing binding and stability of liposomes. 
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1. Introduct ion Fluorescent lanthanide chelates have a long-lived fluo- 
rescence with a large Stokes' shift, facilitating the mea- 
Liposomes can incorporate fluorescent labels and other surement of the fluorescence in a time-resolved mode 
indicator molecules both as encapsulated within the aque- resulting in minimal interference by background fluores- 
ous space (polar compounds) or as embedded in the lipid cence in biological samples and by the scatter of excitation 
membrane (lipophilic species) [1 ]. The ease of preparation light [12]. The stability of lanthanide chelates contrasts that 
and the possibility to introduce molecular ecognition ele- of commonly used organic fluorophores uch as fluores- 
ments such as haptens, glycans, peptides and membrane cein and rhodamine and leads to increased shelf-life of the 
labelled species. Together, these properties have led to proteins on the surface of the liposomes has spurred an 
interest in using liposomes in biotechnological pplications increased use of fluorescent lanthanide chelates in research 
[2-5]. Besides applications involving drug delivery (for and diagnostics [13]. For a lanthanide chelate-based assay, 
review see [6,7]), and more recently, gene therapy [8], the the biomolecule is labelled with a nonfluorescent lan- 
potential for signal amplification inherent o the liposomal thanide chelate by using conventional coupling chemistries. 
encapsulation of different indicator molecules has also After appropriate binding and washing steps, the lan- 
prompted attemps to develop immunological and other thanide ion is released from the labelled species to form a 
assays based on targeted binding of label-carrying lipo- highly fluorescent chelate in a micellar environment [14]. 
somes [9-11]. In the present study, we describe the preparation and 
properties of europium-chelate-loaded liposomes which can 
be used to amplify the fluorescent signal in binding assays. 
Furthermore, by exploiting the strong interaction between 
biotin and streptavidin, we describe the use of Eu-lipo- 
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2. Materials and methods A. Results corresponds of at least three separate liposome 
batches. 
2.1. Materials The recovery of liposomes in the ultracentrifugation 
was determined by using [14C]PC as a tracer and by 
Egg yolk L-phosphatidylcholine (PC) and L-phos- Stewart's assay [15] to measure the lipid concentration. No 
phatidylethanolamine (PE) were purchased from Avanti losses were observed uring this process. 
Polar Lipids (Birmingham, AL, USA). N-(Biotinoyl)-l,2- 
dihexadecanoyl-sn-glycero-3-phosphoethanolamine trieth- 2.3. Time-resolved fluorometric assay 
ylammonium salt (B-PE) was from Molecular Probes 
(Eugene, OR, USA). Cholesterol (CHO) was from Sigma. The amount of europium in the samples was measured 
L-oL-Dipalmitoyl-[2-palmitoyl-l-14C]phosphatidylcholine by using a time-resolved fluorometric DELFIA assay [16]. 
([14C]PC) with a specific activity of 2.054 Gbq/mol was Briefly, 190 ixl of DELFIA enhancement solution was 
from New England Nuclear-DuPont. Europium (III) chlo- added to 10 ~zl of the sample. In the detergent-containing 
ride hexahydrate (EuC13) was supplied by Aldrich and enhancement solution the europium is released as highly 
diethylenetriamine p ntaacetic acid (DTPA) by Fluka. fluorescent micellar complex [17]. After 5 min of shaking 
Porcine pancreatic phospholipase A 2 (PLA 2, EC 3.1.1.4) at room temperature, samples were measured with an 
was purchased from Sigma as an ammonium sulfate sus- ARCUS 1230 time-resolved fluorometer (Wallac, Finland). 
pension and was used after extensive dialysis. In this instrument, he sample is pulsed 1000 per s with an 
DELFIA ® streptavidin-coated microtitration strips (8x12 excitation light of 340 nm. In the period between flashes, 
wells) and DELFIA ® enhancement solution [15 IxM 2- 613-nm fluorescence of the sample is measured for 400 ~s 
naphthoyltrifluoroacetone (2-NTA), 50 IxM tri-n-oc- after a delay time of 400 txs that allows the short-lived 
tylphineoxide (TOPO) and 0.1% (v/v)  Triton X-100 in 0.1 background fluorescence to decay. The photons counted 
M acetate-phthalate buffer, pH 3.2] were obtained from during one second are recorded and expressed as counts 
Wallac (Turku, Finland). per second (cps) [16]. 
Triton X-100 and n-octyl [3-D-glucopyranoside (OG) 
were supplied by Boehringer-Mannheim and Sigma, re- 2.4. Liposome binding assay 
spectively. Polystyrene microstrips were purchased from 
Labsystems (Helsinki, Finland). The binding of Eu-liposomes to streptavidin was mea- 
sured by using a time-resolved fluorometric assay as out- 
2.2. Preparation of  Eu-liposomes lined in Fig. 1. Briefly, 100 Ixl of Eu-liposomes (0.6 txg of 
phospholipid/well) were incubated in streptavidin-coated 
Liposomes were prepared by detergent dialysis as fol- microtiter wells for 2 h at room temperature under gentle 
lows. First, a lipid film PC/PE /CHO (molar ratio, shaking. The wells were washed three times with PBS 
17.3:2.7:8) and the appropriate amount of B-PE (0-5 (0.9% NaC1, 50 mM phosphate buffer, pH 7.4) using an 
mol% of total lipid) was dried from a chloroform solution automatic plate washer (1296-024, Wallac, Finland). Then, 
on the walls of glass container by rotary evaporation. The 200 Ixl of DELFIA enhancement solution and after 5 min 
lipid film was dispersed in 0.15 M NaC1, 20 mM Hepes of shaking at room temperature, samples were measured 
pH 7.4 (buffer A) (1 mg/ml) and solubilized in 1% (w/v)  for fluorescence as above. For control experiments, mi- 
of OG containing the appropriate concentration of Eu- crotiter wells previously coated overnight at 4°C with 100 
DTPA chelate (molar ratio 1:1; 1, 10 and 50 mM) in buffer ill of BSA (42 Ixg/ml) in 0.1 M Na-bicarbonate buffer, 
A. The dialysis was performed in a LIPOSOMAT dialyser pH 9.6 were used in instead of streptavidin coated wells. 
(Dianorm, Munich, Germany) equipped with a cellulose Unless otherwise indicated, all experiments were carried 
membrane (cut-off 10 kDa). To enable a strict control over out with 0.6 ~g of phospholipid/well. 
the concentration of encapsulated europium chelate, the 
Eu-DTPA concentration was maintained at an equal con- 2.5. Liposome permeability measurement 
centration on both sides of the membrane during the first 
60 min of the dialysis. During this time, the liposomes Eu-liposomes (1 mol% of B-PE, 10 mM Eu-DTPA) 
formed as the suspension became slightly opalescent. Sub- were bound to streptavidin coated wells as described above. 
sequently, non-encapsulated uropium chelate was re- Then, 200 ixl of buffer A containing different concentra- 
moved by dialysis against buffer A, containing equal con- tions of Triton X-100 or OG was added. After a 1-h 
centration of DTPA, until no more free europium chelate incubation at room temperature, the wells were washed 
was observed in the dialysate as measured by TRF (about three times with PBS and the europium was released by 
3 h). The resulting suspension of Eu-DTPA-loaded lipo- adding 200 p~l of DELFIA ® enhancement solution and the 
somes (Eu-liposomes)were collected by ultracentrifuga- fluorescence signal was measured. Also, the effect of 
tion (150000 × g, 2 h, 4°C), suspended in buffer A and PLA 2 was tested in a similar manner by adding 100 ~1 of 
re-centrifuged, and finally suspended into 500 ~zl of buffer buffer A containing 1mM CaC12 and different amounts of 
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Fig. ]. Schematic representation of  |iposomaI assay protocol. Liposomes (PC/PE/CHO) including variable amount of B-PE (0-5 tool% of the total lipid) 
and Eu-DTPA chelate ( ] -50  raM) were incubated (]00 I~]/we|]) in streptavidin coated microtiter wells. After a 2-b incubation at room temperature, the 
unbound ]iposomes were removed by washing. The fluorescence of  the immobifised Eu-]iposomes was developed by the addition of  DELFIA ® 
enhancement solution (E.S.), and the fluorescence was measured in an ARCUS time-resolved tluorometer. The treatment refers to the addition of  
detergents and PLA 2, as described in the text (see Section 2). 
PLA 2 and incubated for 3 h at 37°C under shaking, vidin-biotin interaction was used as a model system (Fig. 
Thereafter, the assay was done as above. 1). Biotinylated phosphatidylethanolamine was incorpo- 
rated (0-5 mol% of the total lipids) into the liposomes 
during their preparation. The binding of Eu-liposomes to 
3. Results streptavidin was then measured as the amount of the 
europium released from the bound liposomes after incubat- 
3.1. Preparation of Eu-liposomes ing biotinylated liposomes in streptavidin coated wells. 
The release was achieved by addition of DELFIA dissocia- 
Eu-liposomes were prepared by dialysis from an OG tive enhancement solution containing detergent. Eu-lipo- 
solution of lipids mixture and Eu-DTPA chelate (1-50 somes containing 1 mol% of biotinylated PE bound to 
mM). The detergent was removed uring dialysis in the streptavidin but not to BSA whereas liposomes containing 
Liposomat resulting in the formation of unilamellar lipo- no biotinylated PE did not bind to streptavidin nor to BSA 
somes containing the entrapped marker in a reproducible (Fig. 3A). Thus, both biotin and streptavidin were required 
manner. Eu-liposomes negatively stained with 1% potas- for the binding of liposomes. Furthermore, the presence of 
sium phosphotungstate (pH 7.4), appeared as a relatively a molar excess of free biotin and biotinylated alkaline 
homogeneous population of apparently unilamellar lipo- phosphatase inhibited the binding of Eu-liposomes to im- 
somes (120 _+ 30 nm, n = 400) when studied by transmis- mobilised streptavidin (data not shown). 
sion electron microscopy (Fig. 2). The binding of Eu-liposomes (1 mM Eu-DTPA, 60 ixg 
phospholipid per well) to streptavidin increased with in- 
3.2. Characterisation fthe Eu-liposomes creasing content of biotinylated PE up to 1 mol% of B-PE 
(Fig. 3B). As expected, the fluorescence signal obtained 
To demonstrate the usefulness of lanthanide-chelate- from bound Eu-liposomes (1 mol% B-PE) was also depen- 
loaded liposomes in liposomal binding studies, strepta- dent on the concentration of entrapped Eu-DTPA at the 
concentration range of 1-50 mM (Fig. 3C). 
The dose-dependency of the binding of Eu-liposomes 
(10 mM Eu-DTPA) to streptavidin is shown in Fig. 4A. 
Increasing the amount of Eu-liposomes resulted in in- 
creased fluorescence signals and reached a maximal evel 
at 12 p~g phospholipid/well. The fluorescence obtained 
from the bound Eu-liposomes was correlated to actual 
europium concentrations by using a standard curve (Fig. 
4A inset). We assumed the concentration of europium in 
the liposomes equal to the initial concentration f the label 
because during the formation of the liposomes, the label is 
present at equal concentration  both sides of the dialysis 
membrane. Therefore, from the size (Q 120 nm) and the 
Fig. 2. Electron micrograph ofnegative-stained Eu-liposomes. Liposomes loaded concentration of europium (10 mM), one liposome 
conta in ing  1 mol% o f  B -PE  and  10  mM Eu-DTPA were  prepared  by  is calculated to contain approximately 3000 Eu 3+ ions. 
detergent  d ia lys i s .  The  bar  cor responds  to  200  nm.  Considering binding signals exceeding the background by 
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A 6 reached its maximal evel within a 2-h incubation at room 
temperature (Fig. 4B). 
5 
IBSA[ After a 2-month storage of the Eu-liposomes at 4°C the 
x 
o~ 4 fluorescence signal obtained by the binding assay was still 
about 90% of the value obtained with fresh Eu-liposomes 
8 3 § as measured by TRF. Eu-liposomes containing different 
~, 2 amounts of B-PE showed similar stability indicating that 
_o= the presence of B-PE did not affect to the stability of the 
u_ t liposomes. 
0 ~ - -  
0% B-PE 1% B-PE 3.3. Liposomal permeability measurements 
B 5.o I._ T The potential use of the streptavidin-bound Eu-lipo- 
-- / ~  somes for monitoring membrane permeability was studied 
T° ~ 4.0 by subjecting immobilised liposomes to membrane-de- 
x 
stabilising agents. The effects of the treatments were mea- 
3.0 sured as the europium fluorescence signal remaining asso- 
~, ciated with liposomes. First, the effects of two nonionic 
2.0 
aJ 
L. 
O 
1.0 A 
El. 
50- 
o ,o  i i i l 
0.0 1.0 2.0 3.0 4.0 5.0 
C 35 ~ 
~. 30- ~" 4. 
o g 
~.. 30 ~ 
0 ~ ~ 3" 
e- 
25 ~ 20- 
v 20  =o ~' 1 
EL 10" E (z 15 o =o ~ ;, ~ ~ 1'o 
10 [Eu-DTPA] (riM) 
o o 
~- 5 o 1'o 2'0 a'o 4'0 go go 70 
Phospholipids (I,tg/well) 
0 , 
1 10 50 
Eu-DTPA loaded into the liposomes (mM) 
Fig. 3. Characterisation f the binding of Eu-liposomes to streptavidin. 2.0 
All values are means of three measurements ( + S.D.). (A) Specificity of ~"  
the binding. Eu-liposomes (1 mol% B-PE) and control liposomes were 0 ;L 
loaded with 1 mM Eu-DTPA and bound to BSA and streptavidin coated ,~ 1.6 . l  
wells. (B) Dependency of the binding of liposomes on the biotin-content. O 
Eu-liposomes containing different amounts of B-PE (0-5 mol%) bound ~ 1.2 
to streptavidin. (C) Different concentrations of entrapped Eu-DTPA. o 
Eu-liposomes (6 txg phospholipid/well; 1 mol% B-PE) loaded with 1, 10 
o 0,8 
and 50 mM of Eu-DTPA were bound to streptavidin, tn 
O 
_= 0.4 
ii 
a factor of three as significant, the binding of four atto- 0.0 . . . . .  0 150 300 450 600 750 
moles of liposomes was easily detected. The background 
fluorescence in our assay is defined as the binding of Time (mini 
non-biotinylated liposomes to streptavidin or by binding of Fig. 4. Characteristics of the liposome binding assay. (A) Dose-response 
curve of Eu-liposomes loaded with 10 mM of Eu-DTPA to streptavidin. biotinylated liposomes to BSA and is about 5000 cps. 
Inset shows the standard curve of Eu-DTPA. (B) Time-course of the 
Next, the kinetics of the binding of Eu-liposomes to binding Eu-liposomes (60 IJ-g phospholipid/well) containing 1 mol% 
streptavidin was studied. Using 6 ;xg of phospholipid B-PE and 1 mM of Eu-DTPA. Inset corresponds to a standard curve of 
/wel l  of Eu-liposomes (1 mM Eu-DTPA), the binding Eu-DTPA~ 
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A. Table 1 
20- Effect of PLA 2 on the liposomal permeability 
[CaC12 ] (mM) Fluorescence (cps × 10 -6) Reduction (%) 
15- Buffer a 1.5 - 
0 1.2 20.9 
x 
1 0.2 86.1 
10- 2.5 0.2 87.2 
=o 5 0.2 88.9 
10 0.2 85.8 
o Immobilized Eu-liposomes containing 1 mol% B-PE and 10 mM Eu- 
" DTPA were subjected to 2.4 ixg/well PLA 2 solutions in the presence of 
0- = -- different amounts of Ca 2+ (0-10 mM) (see Section 2). 
0.o0o 0.005 0.010 0.015 0.(J2o 0.025 a Blank corresponds to buffer without enzyme. 
Triton X-100 (% w/v) 
a. gents, a small decrease in the fluorescence was observed at 
20- concentrations below the respective CMCs, whereas at 
concentrations above the CMC, a total release of europium 
occurred (Fig. 5A,B). 
15- '2 Next, we studied the effect of phospholipase A 2 (PLA 2) 
which catalyses the hydrolysis of the fatty acid ester in 
lo- position 2 of 3-sn-phospholipids and thereby increases 
membrane permeability [19]. A dose-dependent release of 
europium was observed on PLA 2 addition starting at a 
_~ dose of 50 ng of enzyme per well and a total release of 
" encapsulated europium occurred at an enzyme concentra- 
0. - = -- tion of 2.4 ixg/well  (Fig. 6). In accordance with the strict 
0.0 011 o'.a 0'.3 014 0'.5 o'.6 0'.r 0'.a 0.9 Ca2+-dependency of PLA 2 [20], no release of europium 
OG (% w/v) was observed from Eu-liposomes treated with PLA 2 (2.4 
Fig. 5. Effect of detergents on the release of europium from immobilised txg/well) in the absence of Ca 2+ (Table 1). 
liposomes. Streptavidin-bound Eu-liposomes containing 1 mol% B-PE 
and 10 mM Eu-DTPA were subjected to (A) Triton X-100 and (B) OG 
(200 Ixl/well), and the bound fluorescence was measured as in Fig. 1. 
4.  D iscuss ion  
detergents, Triton X-100 and OG were studied. The critical In the present work, we have studied the use of eu- 
micelle concentrations (CMC)o f  the detergents are 0.013% ropium as an encapsulated label as a step towards the 
(w/v )  and 0.42% (w/v) ,  respectively [18]. For both deter- development of sensitive liposome-bound assays. With this 
aim, we prepared lanthanide-chelate-loaded liposomes 
1.2.  I~ doped with biotin and characterised their binding to 
I :~ z polystyrene-bound streptavidin. Our preliminary experi- 
a" ments, in agreement with a previous short report [21], 
b 0.9 indicated that europium has to be chelated in order to 
x obtain stable liposomal encapsulation. This is probably due 
to the interaction between the phospholipid headgroup and 
® o.6 free europium ion interfering with the formation of the 
(.I 
'- liposomes [22]. The use of DTPA as chelating compound 
o proved compatible with the preparation of liposomes and 
o.3 provided stable encapsulation of europium. We chose de- 
-= tergent dialysis as the method for the preparation of lipo- 
14. 
somes because it allows a good control over the formation 
0 tt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  of liposomes which are unilamellar and relatively homoge- 
0 0.o01 o.ol o.1 1 10 100 neous in size. Importantly, by detergent dialysis it is also 
[PI_A 2] (pg/welll easy to incorporate functional membrane proteins in the 
lipid bilayer. Generally, wasteful use of the label to be 
Fig. 6. Effect of the PLA 2 on release of europium from immobilised encapsulated is a drawback of the dialysis method. In our 
Eu-liposomes. Different amounts of PLA 2 (100 i, zl/well) were incubated 
with immobilised Eu-liposomes containing 1 mol% B-PE and 10 mM case, however, this is not a major problem because eu- 
Eu-DTPA, and the bound fluorescence was measured as in Fig. 1. ropium chelates are relatively inexpensive. 
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